Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids
Clinical trial NCT02323646 · COMPLETED
Trial details
- NCT number
- NCT02323646
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-12
- Primary completion
- 2017-04-06
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.